The association between aggregate index of systemic inflammation and DXA-measured body composition parameters in adolescents
Systemic inflammation during adolescence may critically influence metabolic and musculoskeletal health, yet comprehensive biomarkers predicting adverse body composition remain underexplored. The aggregate index of systemic inflammation (AISI), integrating neutrophils, platelets, monocytes, and lymph...
Saved in:
Published in | Frontiers in physiology Vol. 16; p. 1612735 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
09.06.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Systemic inflammation during adolescence may critically influence metabolic and musculoskeletal health, yet comprehensive biomarkers predicting adverse body composition remain underexplored. The aggregate index of systemic inflammation (AISI), integrating neutrophils, platelets, monocytes, and lymphocytes, offers a novel metric to assess this relationship.
This cross-sectional study analyzed 3,661 adolescents (aged 12-19 years) from NHANES 2011-2018. AISI was calculated from complete blood counts, and body composition parameters-appendicular lean mass index (ALMI), visceral adipose tissue area (VATA), and total bone mineral density (BMD)-were measured via dual-energy X-ray absorptiometry (DXA). Multivariable linear regression and threshold effect models evaluated associations, adjusting for demographic, metabolic, and lifestyle covariates.
Higher logAISI was associated with lower ALMI (β = -0.189, 95% CI: -0.262 to -0.116), greater VATA (β = 3.017, 1.266-4.769), and reduced BMD (β = -0.017, -0.027 to -0.007). A threshold effect emerged at logAISI = 2.2, beyond which inflammation's impact on VATA and BMD intensified.
Elevated AISI correlates with adverse body composition in adolescents. The identified threshold suggests a potential clinical benchmark for early intervention. These findings underscore systemic inflammation as a modifiable target to mitigate metabolic and musculoskeletal risks during this critical developmental period. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Yi-Jin Zheng, Shenzhen Chronic Disease Prevention Center, China Reviewed by: Jian Huang, University of Texas at Arlington, United States These authors have contributed equally to this work Edited by: Lin Zhang, Lanzhou University, China |
ISSN: | 1664-042X 1664-042X |
DOI: | 10.3389/fphys.2025.1612735 |